Former OBIO CAAP Company iBIONICS announced that it has received funding from the Quebec government’s Life Sciences Strategy.

On August 23rd at 6:00 PM, Biomedical Zone hosting an evening of innovation to bring together entrepreneurs, clinicians, researchers and thought leaders to discuss the impact of artificial intelligence in healthcare.

AlayaCare, a cloud software for home care providers, raises $13.8 million Series B led by iNovia Capital. The funding will be used for expansion in the US market and further technological investment. 

On September 21, join McMaster University's BDC students in a panel discussion and career fair to meet students seeking masters internships, grad recruitment, part-time and summer employment opportunities.

Former OBIO CAAP company, Vasomune and AnGes signed an innovative global Co-Development Agreement to advance an innovative platform targeting vascular leakage and to maximize the opportunity for a Tie2 receptor agonist to benefit patients.

Mackenzie Innovation Institute (Hospital) and Ontario Centres of Excellence (OCE) are conducting an Innovation Procurement Case Study on September 13, 2018, 8:00 AM - 4:00 PM (EST) at 325 Front Street West, Toronto. Breakfast and lunch will be provided.

MassMEDIC will conduct its Annual MedTech Showcase on October 10th, at the Westin Seaport Hotel, Boston. Medtech start-up executives are invited to conduct 10-minute pitches at this conference. 

The federal government renews funding for the Centre for the Commercialization of Regenerative Medicine (CCRM) and the Centre for Probe Development and Commercialization (CPDC) in Hamilton through the Networks of Centres of Excellence (NCE) program.

Grand Challenges Canada seeks bold and innovative ideas for products, services and implementation models that will transform how challenges related to sexual and reproductive health and rights are addressed in low- and middle-income countries. 

The University of Toronto announces plans to build a new 14-storey Innovation Centre, replacing the western portion of the Banting and Best complex, located at the corner of College Street and University Avenue, with expected completion in 2021.

Swift Medical CEO Carlo Perez was recognized as one of the finalists for EY Entrepreneur of the Year 2018. The awards recognize entrepreneurial spirit and purpose-driven leadership for the future of the healthcare industry.

Canadian Technology Accelerator (CTA) for Health IT in Philadelphia is a three-month mentoring and orientation program for small and medium-sized digital health enterprises, with a five-day orientation in Philadelphia with key members of the city's healthcare community.

A new round of Genome Canada’s Genomic Applications Partnership Program (GAPP) funding is now available for research collaborations on developing genomics-derived technologies.

Canadian Technology Accelerator (CTA) San Francisco – Life Sciences is an intensive program run by the Trade Commissioner Service (TCS) team in San Francisco. It offers Canadian companies the opportunity to expand their business in a global hub for the life sciences sector. The program is accepting applications for the winter 2018 cohort, which will run November 2018 – February 2019.

Biotechnology Focus magazine is conducting a survey to gauge Canada’s innovation culture. In support of Global Biotech Week (Sept 24-30), add your voice to the Innovation Report by taking this quick survey by July 27th.

VentureLAB brings you a collaborative workshop offering real-world, practical tools, frameworks and tips for commercializing digital healthcare solutions in the U.S. market.

KisoJi, SoundBite and Zucara, three of Accel-Rx’s portfolio companies, together raised a total of $40 million CDN in follow-on funding to advance the development and commercialization of their technologies.

JLABS Meet with.. Series helps build partnerships with Amgen and AmorChem. Amgen is seeking for opportunities in relation to their capabilities in oncology, bone health, nephrology, metabolic disorders, neuroscience, inflammation, cardiovascular, discovery research and technology. AmorChem involves financing research-stage projects for them to reach pre-clinical proof-of-concept in a semi-virtual mode.